ArticleJournal of nephrology2025
Acute kidney injury and in-hospital mortality in COVID-19: a causal analysis using directed acyclic graphs.
Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute kidney injury (AKI) is a common complication in patients affected by COVID-19 and has been strongly associated with increased mortality. However, its independent contribution remains debated. This study aimed to evaluate the independent association using a directed acyclic graph-based approach.
methodsRetrospective, multicenter cohort study in Medellín, Colombia, from June 2020 to April 2022. AKI was defined according to KDIGO criteria. A directed acyclic graph was constructed to map the hypothesized causal relationship between AKI and mortality, integrating evidence from a comprehensive literature review and expert´s consensus. A Poisson regression model with robust variance was applied to estimate adjusted incidence rate ratios (IRRs) for mortality.
resultsA total of 1722 patients were included, of whom 30.7% developed AKI. Mortality was higher among patients with AKI (58.1% vs. 19.6%). A directed acyclic graph was used to identify a minimal sufficient adjustment set for confounding control. After adjustment, the IRRs for in-hospital mortality were 1.25 (95% CI: 1.09-1.43) for stage 1, 1.62 (95% CI: 1.35-1.93) for stage 2, and 1.64 (95% CI: 1.46-1.85) for stage 3.
conclusionsAKI is independently and significantly associated with an increased risk of mortality in COVID-19 patients. This study makes a novel contribution by applying directed acyclic graphs to enhance causal inference. Directed acyclic graphs provide a rigorous framework for identifying true confounders and avoiding inappropriate adjustment for mediators, thereby reducing bias and improving the validity of causal estimates. In clinical settings where randomized controlled trials are not feasible, the use of directed acyclic graphs represents a robust alternative for exploring causal relationships.
Indexed as
Identifiers
40921966What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.